Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer

Background: Currently, the diagnosis of non-organ-confined bladder cancer (NOCBCa) has a very poor prognosis. For patients with NOCBCa, treatments such as radical cystectomy (RC) and systemic chemotherapy have shown survival benefits. However, the relative survival benefits of trimodal therapy (TMT)...

Full description

Bibliographic Details
Main Authors: Yadong Guo, Xiaoliang Jie, Aihong Zhang, Wentao Zhang, Ruiliang Wang, Junfeng Zhang, Shiyu Mao, Yuan Wu, Longsheng Wang, Ziwei Zhang, Yang Yan, Ping Wang, Xudong Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
non-organ-confined bladder cancer
radical cystectomy
trimodal therapy
SEER data
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01315/full

Similar Items

Similar Items